Market Cap

Idorsia Ltd Market Capitalization:

CHF1.14 Billion

CHF as of July 1, 2023

US$1.27 Billion

business Idorsia Ltd Company Profile

Idorsia Ltd Main Stock Listing

show_chart SIX: IDIA

Market Capitalization History of Idorsia Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $329.83 B
Vertex Pharmaceuticals Incorporated $88.79 B
CSL Limited $85.00 B
Marinomed Biotech AG $84.73 B
Regeneron Pharmaceuticals, Inc. $78.88 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $428.70 B
Lilly $417.05 B
Johnson & Johnson $412.24 B
Novo Nordisk $329.83 B
Merck $275.82 B

Yearly evolution of Idorsia Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2023 CHF2.50 B -34.39%
Jan. 1, 2022 CHF3.81 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Idorsia Ltd Categories

Switzerland languages Healthcare languages Biotechnology
Switzerland Healthcare Switzerland Biotechnology

Stocks & Indices

Idorsia Ltd has the following listings and related stock indices.


Stock: SIX: IDIA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.